Class information for:
Level 1: MOL RECOGNIT SECT//A3 ADENOSINE RECEPTOR//ADENOSINE RECEPTORS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1651 2472 37.8 79%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1347 7852 ADENOSINE//ADENOSINE RECEPTORS//ADENOSINE A2A RECEPTOR

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MOL RECOGNIT SECT Address 108 49% 6% 160
2 A3 ADENOSINE RECEPTOR Author keyword 58 72% 2% 46
3 ADENOSINE RECEPTORS Author keyword 53 24% 8% 190
4 ADENOSINE A3 RECEPTOR Author keyword 41 57% 2% 48
5 IB MECA Author keyword 36 83% 1% 20
6 ADENOSINE RECEPTOR Author keyword 26 20% 5% 114
7 A1 ADENOSINE RECEPTOR Author keyword 25 42% 2% 46
8 ADENOSINE RECEPTOR ANTAGONISTS Author keyword 19 50% 1% 28
9 TRICYCLIC HETEROAROMATIC SYSTEMS Author keyword 17 100% 0% 8
10 LIGAND RECEPTOR MODELING STUDIES Author keyword 15 88% 0% 7

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 A3 ADENOSINE RECEPTOR 58 72% 2% 46 Search A3+ADENOSINE+RECEPTOR Search A3+ADENOSINE+RECEPTOR
2 ADENOSINE RECEPTORS 53 24% 8% 190 Search ADENOSINE+RECEPTORS Search ADENOSINE+RECEPTORS
3 ADENOSINE A3 RECEPTOR 41 57% 2% 48 Search ADENOSINE+A3+RECEPTOR Search ADENOSINE+A3+RECEPTOR
4 IB MECA 36 83% 1% 20 Search IB+MECA Search IB+MECA
5 ADENOSINE RECEPTOR 26 20% 5% 114 Search ADENOSINE+RECEPTOR Search ADENOSINE+RECEPTOR
6 A1 ADENOSINE RECEPTOR 25 42% 2% 46 Search A1+ADENOSINE+RECEPTOR Search A1+ADENOSINE+RECEPTOR
7 ADENOSINE RECEPTOR ANTAGONISTS 19 50% 1% 28 Search ADENOSINE+RECEPTOR+ANTAGONISTS Search ADENOSINE+RECEPTOR+ANTAGONISTS
8 TRICYCLIC HETEROAROMATIC SYSTEMS 17 100% 0% 8 Search TRICYCLIC+HETEROAROMATIC+SYSTEMS Search TRICYCLIC+HETEROAROMATIC+SYSTEMS
9 LIGAND RECEPTOR MODELING STUDIES 15 88% 0% 7 Search LIGAND+RECEPTOR+MODELING+STUDIES Search LIGAND+RECEPTOR+MODELING+STUDIES
10 ALLOSTERIC ENHANCER 13 80% 0% 8 Search ALLOSTERIC+ENHANCER Search ALLOSTERIC+ENHANCER

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 2 AMINO 3 BENZOYLTHIOPHENES 111 88% 2% 52
2 ADENOSINE A1 RECEPTOR BINDING 89 84% 2% 48
3 ADENOSINE 5 N ETHYLURONAMIDE 86 96% 1% 26
4 2 ALKYNYL DERIVATIVES 77 96% 1% 24
5 N 6 BENZYLADENOSINE 5 URONAMIDES 65 95% 1% 21
6 A3 RECEPTOR 50 48% 3% 77
7 CARBOXYLIC CONGENER 41 100% 1% 15
8 A1 ADENOSINE RECEPTOR 35 43% 3% 62
9 HUMAN A3 35 86% 1% 18
10 ELEVATING EXTRACELLULAR ADENOSINE 35 81% 1% 21

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors 2001 1507 326 44%
Adenosine receptors as therapeutic targets 2006 634 194 46%
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update 2011 250 264 41%
The A(3) Adenosine Receptor: History and Perspectives 2015 3 350 56%
NOMENCLATURE AND CLASSIFICATION OF PURINOCEPTORS 1994 1323 111 36%
ADENOSINE RECEPTOR SUBTYPES - CHARACTERIZATION AND THERAPEUTIC REGULATION 1995 447 89 65%
Recent developments in adenosine receptor ligands and their potential as novel drugs 2011 85 167 60%
Pharmacological and therapeutic effects of A(3) adenosine receptor agonists 2012 26 72 64%
Adenosine receptors and their ligands 2000 222 56 88%
The A(3) adenosine receptor: An enigmatic player in cell biology 2008 89 182 59%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MOL RECOGNIT SECT 108 49% 6.5% 160
2 SEZ FARMACOL 12 21% 2.1% 51
3 MOL MODELING SECT 11 36% 1.1% 26
4 FELSENSTEIN MED CLIN TUMOR IMMUNOL 9 83% 0.2% 5
5 NAZL ECCELLENZA SVILUPPO METODOL INNOVAT STUD 9 83% 0.2% 5
6 INTERNAL MED MOL PHYSIOL BIOL PHYS 6 80% 0.2% 4
7 TUMOR CLIN IMMUNOL 6 80% 0.2% 4
8 LBC 6 21% 1.1% 26
9 PHARMACEUT POPPELSDORF 5 50% 0.3% 7
10 DRUG PHARMACOL SCI 4 40% 0.3% 8

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000254793 NEW ENGLAND INFLAMMAT TISSUE PROTECT//MUCOSAL INFLAMMAT PROGRAM//ADENOSINE RECEPTORS
2 0.0000166628 ADENOSINE A2A RECEPTOR//ADENOSINE A2A RECEPTORS//ISTRADEFYLLINE
3 0.0000163303 PROPENTOFYLLINE//ADENOSINE A1 RECEPTOR//A1 RECEPTOR
4 0.0000143439 ANTIADRENERGIC//PHENYLISOPROPYLADENOSINE//DIPROPYLCYCLOPENTYLXANTHINE
5 0.0000139410 KW 3902//2 3 CAMP//ADENOSINE A1 RECEPTOR ANTAGONIST
6 0.0000105985 ADENOSINE PHARMACOLOGY//ANESTHESIA VOLATILE ISOFLURANE NITROUS OXIDE//NBTI SENSITIVE ADENOSINE TRANSPORTER
7 0.0000092070 SPATHOLOBI CAULIS//EHU MED FISIOL POB 699//RABBIT PARIETAL CELLS
8 0.0000076269 FLUORESCENT LIGANDS//RADIORECEPTOR ASSAYS//BODIPY TMR CGP
9 0.0000071995 AGONIST ANTAGONIST DISCRIMINATION//BINDING THERMODYNAMICS//W SSM RATS
10 0.0000061022 XANTHINE OXIDASE INHIBITORS//THIENOTRIAZOLOPYRIMIDINE//A1 ADENOSINE RECEPTOR LIGANDS